Immunogen (IMGN) Misses Q3 EPS by 42c
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Clinical materials reimbursement: 46K
Today's EPS Names:
YRD, CAG, CALM, More
Financial Fact:
Clinical materials reimbursement: 46K
Today's EPS Names:
YRD, CAG, CALM, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q3 EPS of ($0.61), $0.42 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $8.5 million versus the consensus estimate of $33.62 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron Technology (MU) Tops Q4 EPS by $2.26, Offers Guidance
- Enerflex completes Asia Pacific divestiture to Innio Group
- Jabil (JBL) Tops Q4 EPS by 34c, Beats on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
